Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|November 1, 1993
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infectionsA I Hoepelman, H Kieft, M Aoun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitizationF E Coenjaerts, A M Walenkamp, P N Mwinzi, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infectionsA I Hoepelman, A P Sips, J L van Helmond, et al.
The Journal of Infectious Diseases|June 1, 1995
Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment GroupM M Schneider, T L Nielsen, S Nelsing, et al.
The Journal of Infectious Diseases|September 1, 1995
Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivoE Rozdzinski, B Spellerberg, M van der Flier, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndromeH Kieft, A I Hoepelman, M Rozenberg-Arska, et al.
Diabetes Care|June 7, 2000
Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study GroupS E Geerlings, R P Stolk, M J Camps, et al.
The New England Journal of Medicine|December 24, 1992
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment GroupM M Schneider, A I Hoepelman, J K Eeftinck Schattenkerk, et al.
The Journal of Infectious Diseases|June 1, 1994
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infectionP H Frissen, M E van der Ende, C H ten Napel, et al.
International Journal of Antimicrobial Agents|July 27, 1999
A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infectionsG J de Klerk, J H van Steijn, S Lobatto, et al.
Pageof 6